šŸ’° Financial Performance

Revenue Growth by Segment

Total revenue increased to INR 50.00 Lakhs in FY 2024-25 from NIL in the previous year. The company has widened its segments from Transfer Development Rights (TDR) to include Solar Power generation and Pharmaceuticals, though specific revenue splits per segment are not disclosed.

Profitability Margins

The company achieved a Net Profit Ratio of 25.23% in FY 2024-25, a significant recovery from -61.31% in the previous year. Return on Equity (ROE) improved to 2.32% from -1.41% YoY.

EBITDA Margin

Return on Capital Employed (ROCE) is 3% for FY 2024-25 compared to 1% in the previous year, indicating a slight improvement in core profitability from operations.

Capital Expenditure

Not disclosed in absolute INR Cr, but the company plans to import new machineries to improve quality standards and productivity.

Credit Rating & Borrowing

Not disclosed. However, the Debt-Equity ratio increased to 0.12 from 0 due to an increase in current borrowings.

āš™ļø Operational Drivers

Raw Materials

Not disclosed. The company primarily provided services during the year, resulting in an inventory turnover ratio of 0.

Import Sources

The company intends to import new machineries if required to provide better results and cope with changing industry requirements, though specific countries are not named.

Capacity Expansion

Not disclosed for the company. Industry-wide, India aims for 500 GW of renewable capacity by 2030.

Raw Material Costs

Not disclosed as the company reported no purchases for both years in its trade payable turnover ratio calculation.

Manufacturing Efficiency

Capacity utilization metrics are not disclosed. The company focuses on cost reduction and quality improvement through new machinery.

šŸ“ˆ Strategic Growth

Growth Strategy

The company is diversifying its operations from TDR facilitation into Solar Power generation and Pharmaceuticals. It aims to achieve growth through operational improvements, cost reduction, and investing in human resources and training.

Products & Services

Facilitation of Transfer Development Rights (TDR) for real estate developers, Solar Power generation, and Pharmaceutical products.

Brand Portfolio

Emrock Corporation Limited (formerly Vaghani Techno-Build Limited).

New Products/Services

Solar Power generation and Pharmaceutical products are the newly added segments intended to increase profit levels.

šŸŒ External Factors

Industry Trends

The Indian real estate market is projected to reach US$ 5-7 trillion by 2047. India is 4th globally in solar capacity. The pharma sector supplies 40% of generic demand in the US, positioning the company in high-growth sectors.

Competitive Landscape

The TDR market is influenced by demand-supply caps and government regulations like the New Development Control & Promotion Regulation 2034.

Competitive Moat

The company's moat is based on diversification across three distinct high-growth sectors (Real Estate/TDR, Renewables, and Pharma) to mitigate cyclical risks in any single segment.

Macro Economic Sensitivity

The company is exposed to economic, regulatory, and taxation risks. TDR demand is sensitive to the overall real estate market health.

Consumer Behavior

Increased global preference for low-priced, high-quality Indian medicines and government support for renewable energy are driving demand shifts.

āš–ļø Regulatory & Governance

Industry Regulations

Operations are affected by SEBI (LODR) Regulations, the Companies Act 2013, and the New Development Control & Promotion Regulation 2034. Solar power is subject to state-level tariff changes and PPA renegotiations.

āš ļø Risk Analysis

Key Uncertainties

TDR market volatility, weather-related variability in solar generation, and regulatory/R&D risks in the pharmaceutical segment.

Geographic Concentration Risk

Not disclosed, though the registered office is in Ahmedabad, Gujarat.

Third Party Dependencies

Dependency on DISCOMs for solar revenue realization and regulatory bodies for pharma approvals.

Technology Obsolescence Risk

The company plans to import new machineries to cope with changing industry requirements and technological shifts.

Credit & Counterparty Risk

Trade receivable turnover ratio of 1.85 indicates active management of receivables for services provided.